The firm served as lead counsel on behalf of Oklahoma Medical Research Foundation in a patent infringement suit brought in the Northern District of Oklahoma against Alexion Pharmaceuticals. The patents related to complement-inhibition technology and their use in a drug marketed by Alexion to treat a rare, debilitating and life-threatening disease. After replacing OMRF’s previous counsel in the matter and soon after claim construction briefing was complete, we obtained a settlement. It included payment to our client as well as public acknowledgement that individuals affiliated with OMRF were the true inventors of the technology at issue.

Oklahoma Med. Research Found. v. Alexion Pharmaceuticals, Inc., No. 07-163 (N.D. Okla. filed Mar. 15, 2007).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Policy advocacy for a farmer membership organization
Policy advocacy and international market development for a Missouri-based organization that supports 22,000 bean farmers and producers through, more
Damage claims of trust funds, lands and resources for a tribal community
Serves as lead counsel, representing a tribal community’s claims for damages for mismanagement of tribal trust funds, lands and resources the U.S. more
Asbestos property damage litigation for a national building and construction products manufacturer
Served as defense counsel for a national building and construction products manufacturer in landmark asbestos property damage litigation. more
Regulatory and compliance matters for Waffle House
Assisted Waffle House with ongoing federal and state regulatory and compliance matters. more